Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

The power of creativity in healthcare PR

By Lisa Cave

Virtual Medical Education & Training – Engaging Your Advisors Creatively

Creatively engage with your advisors by transforming your medical education and HCP training! Discover how to creatively plan, develop, and execute engaging virtual events, speaker programs, and mentorship activities. Co-create...

Impetus Digital

- PMLiVE

Roche’s Evrysdi tablets granted EC approval to treat spinal muscular atrophy

The neuromuscular disease affects approximately one in every 10,000 babies worldwide

- PMLiVE

VML Health appoints Nick Bartlett as chief executive officer of EU hub

Bartlett most recently served as head of consulting at Uniphar Group

- PMLiVE

Essential agility in an era of change for medical affairs

By Drew Owen and Clare Middleton

- PMLiVE

How AI can humanise data and transform healthcare communications

By Jane Sneddon and Alex Muller

Upcoming report announcement

Cuttsy+Cuttsy and ISPEP highlight key patient insights in new clinical trials report

Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.

Cuttsy + Cuttsy

- PMLiVE

Next-gen Medical Education Technologies to Keep an Eye on in 2025

Dive into 2025's cutting-edge medical education technologies like immersive training, interactive data visualization, and microlearning. Discover how to boost engagement and drive real HCP impact.

Impetus Digital

regeneron headquarters

Regeneron gains rights to Hansoh’s GLP-1/GIP receptor agonist in deal worth $2bn

The candidate is being evaluated in a phase 3 obesity trial and phase 2b diabetes study

- PMLiVE

Takeda receives EC approval for Adcetris combination in Hodgkin lymphoma

The decision marks the second approval for an Adcetris-based regimen for front-line Hodgkin lymphoma

- PMLiVE

Dermaliq and DEBRA partner to advance epidermolysis bullosa drug delivery

Approximately 500,000 people worldwide are affected by the rare genetic skin disorders

- PMLiVE

Inizio Evoke appoints Matthew Hoelzle as chief medical officer

Hoelzle most recently served as executive vice president, medical strategy at Inizio Evoke

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links